Skip to main content
High-risk MDS: Stanozolol improves PFS after effective induction therapy with decitabine
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
High-risk MDS: Stanozolol improves PFS after effective induction therapy with decitabine
User login
Username
Password
Reset your password
concept
Lead
score
Myelodysplastic Syndrome
1
1
Specialty
Lead
score
Hematology-Oncology
1
1